Meet us at EASD 2025 Vienna!

DCB at EASD 2025

The EASD Annual Meeting is an excellent opportunity to stay up to date with recent developments in the diabetes field. The programme features groundbreaking basic research, cutting-edge clinical trial results and in-depth expert debates. Meet with colleagues from around the world and be part of the key discussions that will shape the future of diabetes research and care.

We will be present with different members of our team from different divisions at booth D3.09. Additionally, members of our Lived Experience Panel will also be attending. We are looking forward to attending insightful Scientific sessions, exploring new innovative solutions and above all: networking with, you!

Don’t miss this exciting opportunity to explore the Innovation Zone, where visionary startups showcase their ideas. Meet the innovators in person and discover the future!

You can meet these startup packed with innovative ideas and products: 

• SNAQ App supports diabetes management by analyzing meals counting nutrients, connecting glucose sensors & sharing insights.
• Glucotrack empowers people with diabetes through non-invasive, accurate & easy-to-use monitoring solutions that make daily management simpler & more effective.
• Syntactiq is an AI-powered platform that accelerates diabetes research by collecting comprehensive, consented patient data & transforming it into actionable insights.
• Diabetotech is a nonprofit e-learning platform offering accredited courses in 30 languages on diabetes technology to keep professionals & people with diabetes certified & up to date.
• Fada medical is developing a novel drug diffusion technology to increase the wear time & performance of a cannula to support consistent long term insulin pump use for people with diabetes.
• Digital Oxygen is a healthcare consultancy helping digital health & MedTech companies achieve market access & successful commercialization in Germany.
• Glucube is a non-invasive device that measures blood glucose through the skin & sends real-time results to a smartphone, with cloud storage, alerts & an easy dashboard.
• Alva Innovations has developed a just-in-time filtration platform that removes insulin fibrils during pump therapy, thereby prolonging the lifespan of pump sets & maintaining healthy skin.
• T1D Scout provides the first fully remote Type 1 diabetes screening, letting families check genetic & antibody risk from home with expert guidance.
• YM MEMS MicroPump offers a highly integrated, accurate & secure technology for insulin infusion, empowering the miniaturization & intelligent precision control for insulin pump.
• GlucoSet develops a minimally invasive, real-time glucose sensor that connects to existing arterial catheters in ICUs. Offering accurate continuous monitoring with fast setup & low cost.
• Diabetes Venture Fund backs global startups in diabetes & related complications, offering unique support through Serpentine Ventures & the Diabetes Center Berne.
• PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases & illness progress to intelligently & recommend treatment.
• diateam is an academic innovation platform advancing digital diabetes technology through events, research & annual surveys on digital applications in diabetes care.
• GO-Pen® is the first FDA-cleared reusable insulin pen with user-filled reservoir, built for the 20+ million people worldwide still using syringes for daily injections.